Akela Pharma to cut costs to sustain long-term viability of the ... - Canada NewsWire (press release) PDF Print

Akela's pipeline also includes a growth hormone releasing hormone (GHRH), which is being developed for frailty and wasting in chronic renal disease. ...

read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.